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Introduction:

Conclusions:

IgG4-related disease is a newly recognized
fibroinflammatory disorder characterized by diffuse
lymphoplasmacytic infiltration and IgG4+ plasma
cells.

IgG4-related disease encompasses a spectrum of
fibroinflammatory disorders that can affect multiple
organ systems, including the lungs.

Presentation relies on the primary organ affected.
Pulmonary disease can be especially difficult to
characterize, as its course may mimic various lung
pathologies.

Given the evolving nature of IgG4-related ILD,
diagnosis can be especially difficult given the
multitude of presentations mimicking other infectious,
neoplastic, and inflammatory disease processes.

Case Presentation:

This case highlights the importances of maintaining a
board differential, especially in the setting of
ineffective treatments.

33-year old female with PMH of recent Group B
Streptococcal bacteremia with aortic valve
endocarditis was admitted for severe aortic
insufficiency, necessitating aortic valve
replacement.
Her course was complicated by acute hypoxic
respiratory failure requiring ventilatory support
followed by multiple readmissions for right-sided
necrotizing pneumonia treated with prolonged
courses of antibiotics.

Larger studies could further understanding of this
complex disease.
Figure 1. Initial CT Chest demonstrating extensive multifocal
pneumonia throughout the right lung with areas of
superimposed cavitation/necrosis.

Discussion:
IgG4-related disease was first recognized in 2003
and is now understood as a spectrum of related
diseases.

Patient was ultimately re-admitted for left sided
chest pain and hypoxia. Initial workup showed
elevated inflammatory markers and CT chest with
right-sided, multifocal pneumonia and cavitations.
Microbiology and immunologic studies were
unremarkable.

Pulmonary manifestations may vary depending on
site affected and include diverse presentations
sharing features of other lung pathologies including
pneumonias, cancer, and granulomatous diseases.
Unique to this patient was the recurrent manifestation
of necrotizing pneumonia subjecting her to multiple
protracted courses of antibiotics that were ineffective.

The patient was again treated empirically with
antibiotics but did not improve after 1 month so
underwent bronchoalveolar lavage and right lung
FNA- results were consistent with IgG4-related
ILD.
Treatment was initiated with prednisone 0.6
mg/kg/day and slowly tapered.
Patient was successfully weaned from oxygen
support without further addition of DMARDs.

Figure 3. Membrane staining of plasma cells from right lung
FNA positive for pankeratin CAM 5.2, CD138, and IgG4.

Treatment required final diagnosis via FNA and the
patient was successfully treated with corticosteroids.
Figure 2. Right Lung FNA H&E stain with interstitial fibrosis,
inflammatory lymphoplasmacytic infiltrate.

Figure 4. Comparison of initial chest X-ray with repeat chest xray post therapy demonstrating resolution of pulmonary
edema and infiltrates.
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